Diabetes promotes water retention through several overlapping mechanisms, not just one. High blood sugar draws fluid out of cells and into the bloodstream, insulin signals the kidneys to hold onto sodium (and water follows sodium), damaged blood vessels leak fluid into surrounding tissue, and the hormonal system that regulates blood pressure gets stuck in overdrive. Some diabetes medications add their own fluid-retaining effects on top of all this. The result is that swelling, puffiness, and excess body water are common complaints across both type 1 and type 2 diabetes, and the causes run deeper than most people realize.
How High Blood Sugar Shifts Water Between Compartments
When blood glucose climbs well above normal, it creates an osmotic imbalance. Glucose dissolved in the blood raises the concentration of solutes in the extracellular fluid (the fluid outside your cells). Water naturally moves from areas of lower solute concentration to higher, so it gets pulled out of cells and into the bloodstream and the spaces between tissues. This is why people with very high blood sugar often feel dehydrated at the cellular level even while their legs or ankles look puffy. Research on patients with severe hyperglycemia has shown that this process causes intracellular volume to shrink while extracellular volume expands, sometimes without any change in the total amount of water or solute entering or leaving the body. The redistribution alone is enough to cause visible swelling.1PubMed. Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: theoretical analysis
This osmotic effect is most dramatic during acute episodes of uncontrolled blood sugar, but even chronically elevated glucose contributes to a persistent tilt in how water distributes itself. The kidneys try to compensate by excreting some of the extra glucose in urine, which is why frequent urination is a hallmark symptom of uncontrolled diabetes. But once kidney function starts to decline, that escape valve narrows, and fluid accumulates more easily.
Insulin Tells Your Kidneys to Hold Onto Sodium
Insulin does far more than shuttle glucose into cells. It also acts directly on the kidneys, ramping up sodium reabsorption through multiple channels and transporters in the kidney tubules. Studies have shown that insulin increases the activity of the epithelial sodium channel, the sodium-hydrogen exchanger, sodium-phosphate cotransporters, and Na-K-ATPase, all of which pull sodium back into the body rather than letting it pass into urine.2PubMed. Insulin’s impact on renal sodium transport and blood pressure in health, obesity, and diabetes Where sodium goes, water follows. So when insulin levels are high, the kidneys retain more sodium, and the body retains more water as a consequence.
This matters because the most common form of diabetes, type 2, is closely tied to insulin resistance. In insulin resistance, the body produces extra insulin to overcome tissues that respond sluggishly to it. Blood insulin levels end up chronically elevated. The metabolic tissues may be partly deaf to insulin’s glucose-lowering signal, but the kidneys appear to remain quite responsive to insulin’s sodium-retaining signal. The net effect is a body that struggles to manage blood sugar while simultaneously hoarding salt and water. People with type 1 diabetes who inject insulin can experience a version of this as well, particularly when doses are adjusted upward.
An Overactive Hormonal Pressure System
The renin-angiotensin-aldosterone system, often abbreviated RAAS, is the body’s primary mechanism for regulating blood pressure and fluid volume. In diabetes, this system tends to be chronically overactivated. RAAS activation is considered a primary driver of hypertension in people with diabetes.3PubMed Central. Renin-Angiotensin-aldosterone system in diabetes and hypertension When RAAS is running too hot, the kidneys receive a persistent signal to retain sodium and water, blood vessels constrict, and fluid volume climbs. This is one reason why ACE inhibitors and angiotensin receptor blockers are so commonly prescribed to people with diabetes: they interrupt this cycle at the hormonal level, and doing so has been shown to slow the progression of both the blood vessel damage and the kidney damage that diabetes causes.
RAAS overactivation also intersects with the insulin-driven sodium retention described above. The two systems reinforce each other, creating a feedback loop that makes fluid retention in diabetes stubbornly persistent. Addressing only one arm of the problem, say by restricting dietary salt, often yields disappointing results because the hormonal machinery is still pushing the kidneys to hold on to whatever sodium comes through.
Why People With Diabetes Are More Salt-Sensitive
Not everyone’s blood pressure and fluid balance respond equally to salt intake, but people with diabetes are disproportionately salt-sensitive. Research indicates that hyperinsulinemia, hyperglycemia, and heightened sympathetic nervous system activity all contribute to this elevated salt sensitivity in people who are obese or have type 2 diabetes.4PubMed Central. Salt and hypertension in diabetes In practical terms, this means a high-sodium meal that might cause only a slight, transient rise in blood pressure for a non-diabetic person can produce a more pronounced and longer-lasting increase in blood pressure and fluid retention for someone with diabetes.
This has real dietary implications. Sodium lurks in processed foods, restaurant meals, and canned goods in quantities that can easily exceed recommended limits. For someone with diabetes, that excess sodium gets retained more aggressively and takes longer to clear, compounding the swelling problem. Reducing sodium intake is a standard recommendation for managing blood pressure in diabetes, and the heightened salt sensitivity is one of the main reasons it actually works, at least partially.
Leaky Blood Vessels and Microvascular Damage
Chronic high blood sugar damages the tiny blood vessels throughout the body, and one of the consequences is that those vessels become leakier. Multiple molecular pathways contribute to this. Excess glucose drives the production of inflammatory signals and growth factors, which in turn alter the structure and function of the endothelial barrier, the thin lining of blood vessel walls that normally keeps fluid inside. When this barrier breaks down, plasma seeps out of the blood vessels and into surrounding tissues, producing swelling.5PubMed. Microvascular permeability in diabetes and insulin resistance
This vascular leakiness is what distinguishes the fluid retention in long-standing diabetes from the kind you might get from eating too much salt on an otherwise healthy day. It is not just that the body is holding more water; the plumbing itself is compromised. Fluid escapes the circulation in places it should not, collecting in the feet, ankles, and legs, and sometimes in less visible locations like the lungs or the tissue around the eyes. The damage is progressive: the longer blood sugar stays poorly controlled, the worse the vascular leakage tends to get.
When the Lymphatic System Stops Draining Properly
The lymphatic system acts as the body’s secondary drainage network, collecting fluid that leaks out of blood capillaries and returning it to the bloodstream. In diabetes, this drainage system can itself become impaired. Research in animal models of type 2 diabetes found that the permeability of collecting lymphatic vessels was dramatically increased compared to non-diabetic controls. The defect was tied to disrupted nitric oxide signaling, and correcting that signaling restored the lymphatic barrier.6Oxford Academic (Cardiovascular Research). Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling
When the lymphatic vessels themselves are leaky, fluid that has already escaped the blood vessels cannot be efficiently returned to the circulation. It pools in the tissues instead. This helps explain why some people with diabetes develop persistent, hard-to-treat swelling in the legs and feet that does not respond well to conventional diuretics. The problem is not just that too much fluid is leaking out of blood vessels; it is that the system designed to mop it up is also broken. This area of research is still relatively young, but it adds an important piece to the puzzle of why fluid retention in diabetes can be so resistant to treatment.
Swelling Caused by Diabetes Medications
Some of the very medications used to treat diabetes can worsen fluid retention, which creates an uncomfortable paradox for patients and clinicians alike.
Insulin Edema
Starting insulin therapy, or significantly intensifying it, can trigger a condition known as insulin edema. This is most often seen in patients whose blood sugar has been very high for a prolonged period and who then experience rapid glucose correction once insulin treatment begins.7PubMed Central. Insulin Edema Syndrome due to Rapid Glucose Correction in a Diabetic Patient The swelling can be dramatic, sometimes affecting the legs, face, and hands within days of starting insulin. The mechanism involves insulin’s direct sodium-retaining effect on the kidneys, amplified when high insulin doses meet kidneys that have been losing sodium freely during the period of uncontrolled blood sugar. The condition is generally self-limiting, resolving within a few weeks, but it is under-recognized and can cause significant alarm.
Thiazolidinediones
Thiazolidinediones (commonly known as TZDs, with pioglitazone being the most widely prescribed) are oral diabetes drugs that improve insulin sensitivity. Their well-known side effect is fluid retention. Research suggests that TZDs stimulate sodium reabsorption in the kidney’s collecting duct, though the exact mechanism has been debated. Some studies point to activation of the epithelial sodium channel, while others have not confirmed this pathway and have even reported suppression of that same channel.8PubMed Central. Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms What is not debated is the clinical effect: TZDs can cause meaningful weight gain from water retention, and in people with existing heart problems, this extra fluid can tip the balance toward heart failure. This side effect is one reason TZDs have fallen out of favor relative to newer drug classes.
How SGLT2 Inhibitors Work in the Opposite Direction
A newer class of diabetes drugs, SGLT2 inhibitors (sometimes called gliflozins), actually reduces fluid retention rather than contributing to it. These medications block a transporter in the kidneys that normally reabsorbs glucose and sodium back into the blood. The result is that glucose and sodium are excreted in the urine, producing a mild but sustained osmotic diuresis.9Nature Reviews Nephrology. Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation This differs from how conventional diuretics work. Traditional water pills reduce sodium reabsorption further down in the kidney tubules and can cause sharp, sometimes excessive fluid loss. SGLT2 inhibitors act earlier in the process, producing a gentler effect that reduces fluid overload, lowers blood pressure, and decreases whole-body sodium content without the aggressive dehydration risk that loop diuretics carry.10American Journal of Hypertension. State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications – Section: SGLT2I REDUCE FLUID OVERLOAD AND IMPROVE HEART FAILURE OUTCOME
Clinical data confirms that SGLT2 inhibitors reduce body weight, a marker of fluid called brain natriuretic peptide, and measurable body fluid parameters within the first week of use. The benefit appears to be greatest in patients who start out with the most excess extracellular fluid.11BioMed Central / Diabetology & Metabolic Syndrome. The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease – Section: RESULTS These drugs have become an increasingly central part of diabetes management, not just for glucose control but for their cardiovascular and kidney protective effects, which are at least partly explained by their ability to address the fluid overload that diabetes creates.
Fluid Retention You Can See in the Eye
One of the most striking examples of diabetes-driven water retention happens in the retina. Diabetic macular edema occurs when fluid accumulates in the central part of the retina, the macula, which is responsible for sharp central vision. The process starts with damage to the retinal blood vessels, which leads to capillary leaking driven by upregulation of vascular endothelial growth factor (VEGF) in response to reduced oxygen delivery.12PubMed Central. Diabetic macular edema: Evidence-based management The blood-retinal barrier, which normally keeps fluid tightly controlled in the eye, breaks down through many of the same inflammatory and oxidative pathways that damage blood vessels elsewhere in the body.13PubMed Central. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
What makes macular edema particularly interesting from a fluid-balance perspective is that the swelling in the eye may be connected to whole-body fluid status, not just local retinal damage. Research has found that a person’s extracellular fluid status, measured as the ratio of extracellular water to total body water, is a meaningful predictor of macular edema risk, independent of other factors like kidney damage and age.14Frontiers in Medicine. Clinical Relevance of Body Fluid Volume Status in Diabetic Patients With Macular Edema This suggests that the systemic fluid overload in diabetes does not just cause ankle swelling; it may actively worsen organ-specific complications like vision loss. Managing overall fluid balance could therefore have benefits beyond the obvious cardiovascular ones.
Chronic Venous Insufficiency as a Compounding Factor
Diabetes does not cause fluid retention in a vacuum. It often coexists with other conditions that independently promote swelling, and chronic venous insufficiency is a common one. This condition occurs when the valves in the leg veins stop functioning properly, allowing blood to pool rather than returning efficiently to the heart. People with type 2 diabetes are at higher risk for chronic venous insufficiency, and the symptoms, including leg heaviness, swelling, and skin changes, can overlap with and amplify the fluid retention that diabetes itself causes.15Muhammadiyah Medical Journal. The Severity Measurement of Chronic Venous Insufficiency in Patients with Type 2 Diabetes Mellitus Using Duplex Sonography
The overlap matters because treatment differs. Swelling from venous insufficiency responds to compression stockings and leg elevation in ways that fluid retention from kidney-driven sodium hoarding does not. Conversely, a diuretic that helps clear fluid from sodium retention will do little for blood pooling behind a faulty valve. When both conditions are present, which is common, addressing only one will leave the patient still dealing with swollen legs and feet. Clinicians sorting out why a person with diabetes has edema often need to evaluate venous function alongside kidney function, cardiac output, and medication effects to figure out which mechanisms are contributing and in what proportion.
Why Standard Diuretics Often Disappoint
Given how many different mechanisms feed into diabetes-related fluid retention, it is not surprising that a simple water pill often fails to solve the problem. Loop diuretics like furosemide can force the kidneys to excrete more sodium and water, but they do nothing about the leaky blood vessels, the overactive RAAS, the lymphatic dysfunction, or the osmotic fluid shifts from high blood sugar. They also trigger compensatory responses: once the diuretic wears off, the kidneys aggressively reclaim sodium, sometimes resulting in rebound fluid retention that leaves the person no better off than before.
This is part of why modern diabetes management has shifted toward addressing the upstream causes rather than just bailing out the excess water. SGLT2 inhibitors tackle the problem at the kidney transporter level while simultaneously lowering blood sugar. ACE inhibitors and angiotensin receptor blockers dial down the RAAS. Tight glucose control reduces the osmotic shifts and slows the vascular damage that causes leaking. Compression therapy and physical activity address the venous and lymphatic components. No single intervention covers all the pathways, which is why fluid retention in diabetes usually requires a multi-pronged approach and why it tends to worsen when any part of the management plan slips.
Recognizing Fluid Retention Early
Many people with diabetes chalk up swollen ankles or unexplained weight gain to aging, diet, or inactivity, without recognizing that their diabetes may be driving the problem. A few practical signs worth paying attention to include pitting edema (pressing a finger into the shin and seeing the indentation linger), shoes feeling tight by the end of the day when they fit fine in the morning, rapid weight fluctuations of a few pounds over a day or two (which almost always reflects water rather than fat), and puffiness around the eyes upon waking. Shortness of breath that worsens when lying flat can signal fluid accumulation in or around the lungs and warrants prompt medical evaluation.
Tracking daily weight at the same time each morning is one of the simplest tools for catching fluid retention trends early. A gain of more than about two pounds overnight, repeatedly, points to fluid rather than caloric intake. Bringing that information to your doctor can prompt a review of kidney function, medication effects, and blood sugar control before the fluid retention becomes a bigger clinical problem.